Kotagal Shashi Kant

Kotagal Kant practices at UC Medical Center in Cincinnati, Ohio.

Kotagal Kant's NPI, 1235195942, was assigned on April 21, 2006. Kotagal Kant graduated from All India Institute of Medical Sciences in 1970. Kotagal Kant holds Ohio license 35-039100.

Kotagal Kant's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Kotagal Kant's primary practice is UC Medical Center in Cincinnati, Ohio. Kotagal Kant is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Kotagal Kant to 1 more dialysis center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kotagal Kant practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Kotagal Kant's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Kotagal Kant is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Kotagal Kant's licenses on file in 3 states: Ohio, Colorado and Indiana.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney cysts and kidney disease among the conditions Kotagal Kant treats.

CMS data shows 110 Medicare services from Kotagal Kant across 4 procedure codes in 2024, for 57 Medicare patients. Medicare paid $16,685 for them.

CMS counts 57 Medicare patients who saw Kotagal Kant in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 4.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kotagal Kant's median patient age at 64, with 47% women.

In 2024, Kotagal Kant wrote 291 Medicare Part D claims for 72 patients. 80% of them were for generic drugs. CMS names the drug for 121 of them, across 7 drugs with 11 or more claims each, at $23,035 in total drug cost. In 2023, CMS named 563 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Kotagal Kant for performance year 2024, reported as part of a group. Kotagal Kant accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Kotagal Kant in 2011. The most frequent topics are Calcium, Parathyroid Hormone and Renal Dialysis. Kotagal Kant's most frequent co-authors are Marializa V. Bernardo, MD, PA, Udayan Yogendra Bhatt, MD and Stephen Zale Fadem, MD.

Dmand AI links Kotagal Kant to 1 clinical trial. Conditions studied include Nephritis, Hereditary and Collagen Diseases.

CMS Open Payments shows 44 general payments to Kotagal Kant from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 80% of the total. Amgen Inc. paid the most, $30,487.

Dmand AI lists 1 award for Kotagal Kant, most recently CMS Stage 1 EHR in 2012.

Kotagal Kant graduated from All India Institute of Medical Sciences in 1970.

Kotagal Kant is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.